Discussion: The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant Bleeding

Plast Reconstr Surg. 2018 Jul;142(1):250-251. doi: 10.1097/PRS.0000000000004528.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Enoxaparin*
  • Fibrinolytic Agents
  • Humans
  • Risk
  • Venous Thromboembolism*
  • Venous Thrombosis

Substances

  • Anticoagulants
  • Enoxaparin
  • Fibrinolytic Agents